Adagio Medical Holdings Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $0-100.0% YoYTTM through 30 Jun 2026
Net Income -$25.1MTTM through 30 Jun 2026
Free Cash Flow -$16.6MTTM through 30 Jun 2026
Margins
| Current |
|---|
Returns
-425.9%ROE
-62.0%ROA
Balance Sheet Health
Debt / Equity-59.85x
Current Ratio1.41x
Net Debt$11.2M
Cash & Equivalents$7.7M
Quality Metrics
Altman Z-Score-6.35
Piotroski F-Score3 / 9
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $0
Diluted EPS-$1.27TTMFY2025: $-1.51
Dividend
No dividend
Capital Allocation
R&D Spend$10.2M
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.